Identity on this record
Chemical name: Bremelanotide (PT-141).
Common synonyms: PT-141, melanocortin receptor agonist peptide.
CAS number: 189691-06-3 (registry entry).
Structural class: Cyclic heptapeptide, α-MSH analogue lineage.
Appearance: White lyophilised powder.
Catalog strength: 10 mg vial.
Those identifiers describe PT-141 as a substance. They do not describe a particular vial. The vial is identified by the name, the nominal fill, and the lot number on its label, checked against the published certificate.
What the catalogue actually sells
PT-141 10mg is the 10 mg lyophilized unit, listed at AED 349 before VAT. The product record stores that sealed unit at 2–8 °C.
Prices are merchandise prices in AED, exclusive of VAT. VAT is added at checkout. A price on this summary is the figure on the product record for PT-141, not a delivered-cost quote. Ordering context that already exists for this compound: PT-141 research guide.
Lots and certificates
Lot VL-PT141-20260323 is the catalogue certificate for PT-141 10mg. Read it on PT-141 10mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.
How the compound record describes the literature
Developed from melanotan peptide research programs; advanced in clinical contexts outside VaultLabs scope. Research material supply supports in vitro and preclinical model literature only.
Topics named on the PT-141 record, as literature context rather than as outcomes VaultLabs claims: Melanocortin receptor binding assays; Central vs peripheral signaling models; Receptor selectivity studies.
That is context for identifying PT-141. It is not a claim that a vial produces a result in a person, an animal, or a study VaultLabs has not published. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
Points the monograph already states
Points already written on the PT-141 monograph, so a reader can check them against that page:
Generic name bremelanotide; CAS registry number 189691-06-3.
A cyclic peptide and a metabolite of melanotan II, differing in that the C-terminal amide of MT-II is replaced by a carboxylic acid.
Acts at melanocortin receptors with principal research interest at MC4R.
Approved as a prescription medicine in the United States under a specific indication; VaultLabs research material is not that product and is not supplied for human use.
Melanocortin-receptor research also examines pigmentation pathways, which is where the structural relationship to melanotan II is most visible.
Dispatch and the research-use boundary
VaultLabs dispatches PT-141 from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
The full narrative record is the PT-141 compound monograph. Handling of the sealed unit is the PT-141 storage guide. Questions are collected on the PT-141 FAQ. How it differs from neighbouring records is the PT-141 comparison.